Limited Fibrin Specificity of Tissue-type Plasminogen Activator and Its Potential Link to Bleeding
- 30 November 1995
- journal article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 6 (6) , 19S-23S
- https://doi.org/10.1016/s1051-0443(95)71243-x
Abstract
No abstract availableKeywords
Funding Information
- Heart and Stroke Foundation of Canada
This publication has 13 references indexed in Scilit:
- Coronary thrombolysis with Desmodus salivary plasminogen activator in dogs. Fast and persistent recanalization by intravenous bolus administration.Circulation, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- Thrombolytic properties of Desmodus rotundus (vampire bat) salivary plasminogen activator in experimental pulmonary embolism in ratsBlood, 1992
- Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits.Circulation, 1991
- Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activatorBlood, 1990
- MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarctionThe Lancet, 1990
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Studies on the kinetics of plasminogen activation by tissue plasminogen activatorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
- On the Regulation and Control of FibrinolysisThrombosis and Haemostasis, 1980